Black Bird Biotech, Inc.
$0.00+0.00%(+$0.00)
TickerSpark Score
48/100
80
Valuation
40
Profitability
55
Growth
36
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BBBT research report →
52-Week Range50% of range
Low $0.00
Current $0.00
High $0.00
Companyblackbirdpotentials.com
Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites.
- CEO
- Nelson Grist
- IPO
- 2009
- Employees
- 4
- HQ
- Argyle, TX, US
Price Chart
-99.00% · this period
Valuation
- Market Cap
- $98.41K
- P/E
- -0.02
- P/S
- 1.19
- P/B
- -0.05
- EV/EBITDA
- -0.60
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -67.71%
- Op Margin
- -1560.42%
- Net Margin
- -2009.09%
- ROE
- -16554.55%
- ROIC
- -6571.45%
Growth & Income
- Revenue
- $82.56K · -20.96%
- Net Income
- $-1,658,766 · 8.42%
- EPS
- $-0.01 · 46.24%
- Op Income
- $-1,288,333
- FCF YoY
- -3.45%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.89
- Avg Volume
- 1.36M
Get TickerSpark's AI analysis on BBBT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 15, 09 | Collins Jeffrey A | other | 0 |
Our BBBT Coverage
We haven't published any research on BBBT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BBBT Report →